Psychedelics & Alternative
20 videos · last 6 months shuffled daily, then older videos newest first
▶
56:23 Psychedelics for IBS: Inside the First Clinical Trial with Erin Mauney, MD
Dr. Erin Mauney, a pediatric gastroenterologist and researcher at Harvard and Massachusetts General Hospital, on one of the first clinical trials of psilocybin-assisted therapy for patients with treatment-resistant IBS.
▶
49:31 How THC Alters Brain Networks
Jodi M. Gilman, PhD, of Harvard Medical School and Massachusetts General Hospital presents a double-blind randomized crossover study of 128 regular cannabis users on how THC alters brain networks, at the Center for Medicinal Cannabis Research.
▶
26:46 MDMA, Empathy, and Openness in Couples Therapy
Clinical psychologist Anne Wagner, founder of the Remedy Institute, discusses her trial of MDMA-assisted couples therapy for PTSD, including the trial process, exclusions, unblinding and the FDA decision on MDMA, in an OPEN Foundation interview at ICPR.
▶
4:04 Inside California's First Cannabis Driving Study in Nearly 40 Years
The California DMV and Highway Patrol have launched the state's first major cannabis-impaired driving study in nearly 40 years, testing how higher-potency cannabis affects driving and how well current roadside methods detect it.
▶
56:13 First-in-Human MEAI Trial: Yale & Johns Hopkins Researchers Discuss CMND-100
Investigators from Yale and Johns Hopkins, with Clearmind CEO Adi Zuloff-Shani, discuss the first-in-human trial of CMND-100, an MEAI-based compound for alcohol use disorder.
▶
25:12 How Will FDA Regulate Psychedelics?
The Cancer Letter on the FDA's final guidance for sponsors running trials of psychedelics — psilocybin, LSD and MDMA — and what it means for psycho-oncology.
▶
42:27 CBD Pilot Trial in Anorexia Nervosa
Guido Frank, MD, Professor of Psychiatry at UC San Diego, presents a randomized, placebo-controlled pilot trial of CBD in 32 adult women with anorexia nervosa, covering safety, pharmacokinetics and eating disorder measures, at a CMCR investigators meeting.
▶
11:24 Minnesota Clinic Running Psychedelic Drug Trials
Dr. Manoj Doss, founder and CEO of the Institute for Integrative Therapies, tells FOX 9 about the Eden Prairie clinic's role in clinical trials testing psychedelic treatments for PTSD and depression and the race to develop FDA-approved psychedelic drugs.
▶
33:43 Psychedelic Therapy Trials: Evidence and Methods
Psychiatrist and researcher Sandeep Nayak discusses psychedelic clinical trials, the methodological problems in the field, the FDA decision on MDMA and which research questions matter most, in an OPEN Foundation interview at ICPR.
▶
10:46 The Big Biz Show Interviews Jonathan C. Javitt, NRx Pharmaceuticals
Jonathan C. Javitt, M.D., M.P.H., founder of NRx Pharmaceuticals, on NRX-101 and the Phase 2b/3 trial comparing it with lurasidone in suicidal bipolar depression.
▶
4:27 Iraq War Veteran Says MDMA Saved His Life and Helped His PTSD
Iraq War Veteran participated in a clinical trial by MAPS of MDMA and the trial found 67% of patients who tried MDMA lost their PTSD symptoms.
▶
3:05 CBD Clinical Trials to Reduce Anxiety
Staci Gruber is running clinical trials of CBD, the "non-psychoactive" part of the cannabis plant, to treat anxiety as shown in this video from PBS' Nova.
▶
4:09 Lead Researcher on Psilocybin Therapy Trial for Clinicians
Dr. Anthony Back of UW Medicine discusses a clinical trial of psilocybin-assisted psychotherapy for front-line clinicians burned out and depressed during the COVID-19 pandemic, published in JAMA Network Open.
▶
6:36 MDMA Clinical Trials: One First Responder MAPS Out a New Life
This video by ABC in Northern California looks at the use of clinical trials of MDMA for Post Traumatic Stress Disorder (PTSD) and the case of Nick Watchorn, who was a 16 year police veteran in Australia that one day responded to a massacre.
▶
4:08 Johns Hopkins Medicine Studies Magic Mushrooms to Stop Smoking
A woman participated in a clinical trial at Johns Hopkins University to quit smoking using magic mushrooms, also known as psilocybin, and she stopped her 40-year smoking habit after taking psilocybin.
▶
14:51 Psilocybin, Love and Connection Brought Together in Clinical Trial
Johns Hopkins Researcher discusses Clinical Studies for Psilocybin (Magic Mushrooms), along with the role of love and connection at a TEDx Talk.
▶
53:57 Early Clinical Trials with Psychedelics and PTSD From PBS
PBS looks at use of Psychedelics including Psilocybin and MDMA with a look at use of the drugs in treating depression in cancer patients and a clinical trial from MAPS using MDMA to to treat PTSD in a former US Soldier.
▶
21:56 Ketamine for Suicidal Depression: Benefits and Risks
Jonathan Javitt, founder and chief scientist of NRx Pharmaceuticals, gives a keynote on the benefits and risks of ketamine for suicidal depression at the Sachs Neuroscience Innovation Forum.
▶
13:34 LSD for Anxiety? Study Finds One Dose Helps for Months
Dr. Josh Eloge, Associate Director at Rush’s Depression Treatment Research Center, joined "ChicagoNOW" to explain LSD research and where psychedelic therapy is headed.
▶
1:28 Clinical Trials For Generalized Anxiety Disorder Using LSD Like Drug
A Ft. Lauderdale research site is conducting clinical trials of a LSD-like drug to treat Generalized Anxiety Disorder.